← Leaderboards
Edward Hook III
University Of Alabama At Birmingham
$10,883,091
Attributed
$10,883,091
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $3M · FY2011–16$5M$3.8M$2.5M$1.3M$0
'11
'12
'13
'14
'15
'16
Funding mix
By agency
NIH$10,883,091 · 2
By mechanism
N01$9,627,795 · 2
N02$1,255,296 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Alabama At Birmingham
Same institution · by research overlap
- William M Geisler$14,663,241
- Isabel C Scarinci$19,061,797
- Jane R. Schwebke$12,395,911
- Edward E Partridge$43,798,134
- Edward W Hook$14,329,104
Others in their field
Top investigators on “Laboratory Personnel”
- David Heimbrook · Leidos Biomedical Research, Inc.$336,724,410
- Judith S. Currier · University Of California Los Angeles$272,544,271
- Jeffrey P Krischer · University Of South Florida$240,639,298
- Michael David Hughes · Harvard University D/B/A Harvard School Of Public Health$224,694,926
- Daniel R Kuritzkes · Brigham And Women'S Hospital$221,877,929
- Richard K. Wilson · Washington University$201,137,538
Research focus
Laboratory PersonnelClinical ResearchClinical Research SiteClinical TrialsClinical Trials Cooperative GroupProtocol DevelopmentLeadershipTrainingBiologicalSexually Transmitted DiseasesSample CollectionResearch InfrastructureAreaHigh PrevalenceDeveloping CountriesPrevalenceIncidenceContractorAdolescentWomanChlamydia TrachomatisDiagnosticNeisseria GonorrhoeaeContracts
Grant awards (18)
Phase II Trial of Therapeutics for Neisseria Gonorrhoeae - STICTG$386,910
N01 · FY2016 · AI · contact PI
Development of Diagnostics for Chlamydia$32,261
N01 · FY2016 · AI · contact PI
Sexually Transmitted Infections Clinical Trials Group$110,870
N01 · FY2015 · AI · contact PI
Development of Diagnostics for Chlamydia$36,619
N01 · FY2015 · AI · contact PI
Phase II Trial of Therapeutics for Neisseria Gonorrhoeae - STICTG$1,255,296
N02 · FY2014 · AI · contact PI
Sexually Transmitted Infections Clinical Trials Group$829,430
N01 · FY2014 · AI · contact PI
Development of Diagnostics for Neisseria Gonorrhoeae - STICTG$467,698
N01 · FY2014 · AI · contact PI
Development of Diagnostics for Chlamydia Trachomatis - STICTG$123,889
N01 · FY2014 · AI · contact PI
Sexually Transmitted Infections Clinical Trials Group$33,199
N01 · FY2014 · AI · contact PI
Sexually Transmitted Infections Clinical Trials Group$1,072,457
N01 · FY2013 · AI · contact PI
Sexually Transmitted Infections Clinical Trials Group$938,097
N01 · FY2013 · AI · contact PI
Sexually Transmitted Infections Clinical Trials Group$1,487,007
N01 · FY2012 · AI · contact PI
Sexually Transmitted Infections Clinical Trials Group$846,025
N01 · FY2012 · AI · contact PI
Sexually Transmitted Infections Clinical Trials Group$240,179
N01 · FY2012 · AI · contact PI
Sexually Transmitted Infections Clinical Trials Group$1,435,615
N01 · FY2011 · AI · contact PI
SEXUALLY TRANSMITTED INFECTIONS CLINICAL TRIALS GROUP$817,780
N01 · FY2011 · AI · contact PI
Sexually Transmitted Infections Clinical Trials Group$619,411
N01 · FY2011 · AI · contact PI
SEXUALLY TRANSMITTED INFECTIONS CLINICAL TRIALS GROUP$150,348
N01 · FY2011 · AI · contact PI